Given QIN may ask SH to support a RI, it's a big miss to not post the financials after declaring they'd be ready on or before Nov 10. @Marla are you still about?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%